Immune Thrombocytopenia
BASICS
DESCRIPTION
- Immune thrombocytopenia (ITP) is an acquired autoimmune disorder characterized by:
- Isolated thrombocytopenia (platelet count formally <100,000/mm3, typically <20,000/mm3)
- Increased platelet destruction
- Increased number of megakaryocytes in the bone marrow
- Primary ITP implies absence of other causes or disorders that may be associated with thrombocytopenia.
- Secondary ITP refers to immune-mediated thrombocytopenia with an underlying cause (e.g., medications, infections, autoimmune disease, immune dysregulation syndromes).
- Phases of ITP
- Newly diagnosed (acute) ITP: ITP within 3 months of initial diagnosis
- Persistent ITP: ITP between 3 and 12 months from initial diagnosis
- Chronic ITP: ITP lasting >12 months after initial diagnosis
EPIDEMIOLOGY
- Most common acquired platelet disorder in childhood
- Incidence is 5 to 10/100,000 children per year (<15 years of age)
- Males and females are equally affected in childhood ITP but mild male predominance in younger children
- Female-to-male ratio is 2:1 in adult and chronic ITP
- Median age at diagnosis is 4 years.
- Children aged <1 year or >10 years are more likely to develop chronic ITP.
PATHOPHYSIOLOGY
- Thrombocytopenia due to increased destruction of antibody-coated platelets by tissue macrophages in the reticuloendothelial system, particularly the spleen
- It is hypothesized that antibodies (usually immunoglobulin G [IgG]) generated in response to foreign antigen or medications cross-react with platelet membrane glycoproteins (most commonly IIb/IIIa and Ib/IX).
- Other mechanisms of immune dysregulation have been implicated, including possible impaired platelet production, limiting the ability to compensate for destruction.
- Typical bone marrow aspirate shows increased numbers of immature megakaryocytes.
COMMONLY ASSOCIATED CONDITIONS
- ITP often follows a viral syndrome by a few weeks; this may be associated with higher likelihood of spontaneous recovery.
- In younger children, primary ITP is the most common etiology.
- Secondary ITP is seen with autoimmune disorders (e.g., systemic lupus erythematosus, autoimmune lymphoproliferative syndrome, common variable immunodeficiency).
- HIV
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Cabana, Michael D., editor. "Immune Thrombocytopenia." 5-Minute Pediatric Consult, 9th ed., Wolters Kluwer, 2025. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/5-Minute-Pediatric-Consult/618188/all/Immune_Thrombocytopenia.
Immune Thrombocytopenia. In: Cabana MDM, ed. 5-Minute Pediatric Consult. Wolters Kluwer; 2025. https://peds.unboundmedicine.com/pedscentral/view/5-Minute-Pediatric-Consult/618188/all/Immune_Thrombocytopenia. Accessed June 10, 2026.
Immune Thrombocytopenia. (2025). In Cabana, M. D. (Ed.), 5-Minute Pediatric Consult (9th ed.). Wolters Kluwer. https://peds.unboundmedicine.com/pedscentral/view/5-Minute-Pediatric-Consult/618188/all/Immune_Thrombocytopenia
Immune Thrombocytopenia [Internet]. In: Cabana MDM, editors. 5-Minute Pediatric Consult. Wolters Kluwer; 2025. [cited 2026 June 10]. Available from: https://peds.unboundmedicine.com/pedscentral/view/5-Minute-Pediatric-Consult/618188/all/Immune_Thrombocytopenia.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Immune Thrombocytopenia
ID - 618188
ED - Cabana,Michael D,
BT - 5-Minute Pediatric Consult
UR - https://peds.unboundmedicine.com/pedscentral/view/5-Minute-Pediatric-Consult/618188/all/Immune_Thrombocytopenia
PB - Wolters Kluwer
ET - 9
DB - Pediatrics Central
DP - Unbound Medicine
ER -

5-Minute Pediatric Consult

